| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.048 | 0.6 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |